Menu Search
Equities

Edwards Lifesciences Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
EWL:MUN

Edwards Lifesciences Corp

Actions
  • Price (EUR)66.42
  • Today's Change-1.58 / -2.32%
  • Shares traded2.00
  • 1 Year change-3.93%
  • Beta0.9437
Data delayed at least 15 minutes, as of Feb 06 2026 07:06 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

  • Revenue in USD (TTM)5.88bn
  • Net income in USD1.34bn
  • Incorporated1999
  • Employees15.80k
  • Location
    Edwards Lifesciences CorpOne Edwards WayIRVINE 92614United StatesUSA
  • Phone+1 (302) 658-7581
  • Fax+1 (302) 655-5049
  • Websitehttps://www.edwards.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		EW:NYQ since
announced		Transaction
value
Vectorious Medical Technologies LtdDeal completed04 Sep 202504 Sep 2025Deal completed-3.09%497.00m
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.